Home | Founder | What's New | In The News | Consulting | |||||||
H1N1 Consulting Paradigm Shift Intervention Monitoring |
Audio:Apr21
Apr26
May19
Jun16
twitter
Commentary
Several of the recent sequences are from samples which have used previously to isolate virus on mammalian (dog kidney MDCK cells), which have gal 2,6 receptors (found in high concentrations in the human upper respiratory tract). Thus, H1N1 that is wild type at positions 225 or 226 will be selected when grown on MDCK cells, but those samples with the more clinically relevant changes (D225G, D225N, or Q226R), will be most easily detected when isolated in eggs. The isolation using the earlier samples yielded sequences that matched the mammalian isolates at the other positions, but had changes at position 225 or 226 (D225N and Q226R detected in A/Mississippi/07/2011, with two Chihuahua sub-clades, A/Pennsylvania/02/2011 and A/Maryland/04/2011, having Q226R). These receptor binding domain changes appended onto the sequence identified in mammalian cell isolates raises serious concerns that the number of receptor binding changes on mammalian cell isolates (the vast majority of CDC isolates) are significantly undercounted and these false negatives support the data suggesting that these changes are spontaneous and poorly transmitted. The data using egg isolates highlights the increased frequency of these changes and raises serious pandemic concerns associated with the significant undercount. Media Link Recombinomics
Presentations |
||||||||||
|
Webmaster:
webmaster@recombinomics.com
© 2011
Recombinomics. All
rights
reserved.